{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:23:33Z","timestamp":1757618613666,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10482-025-02113-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:24:44Z","timestamp":1752139484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the impact of HIS-1 and HSP-70 genes on drug response and pathology of Leishmania major using antisense oligonucleotides"],"prefix":"10.1007","volume":"118","author":[{"given":"Fatemeh","family":"Javani Jouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber","family":"Zafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Vazini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Rahimi Esboei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2113_CR1","first-page":"101","volume":"33","author":"NE Aronson","year":"2019","unstructured":"Aronson NE, Joya CA (2019) Cutaneous leishmaniasis: updates in diagnosis and management. Infect Dis Clin 33:101\u2013117","journal-title":"Infect Dis Clin"},{"key":"2113_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/cells9010137","volume":"9","author":"S Bajan","year":"2020","unstructured":"Bajan S, Hutvagner G (2020) RNA-based therapeutics: from antisense oligonucleotides to miRNAs. Cells 9:137","journal-title":"Cells"},{"key":"2113_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192236","volume":"13","author":"M Bamorovat","year":"2018","unstructured":"Bamorovat M, Sharifi I, Aflatoonian MR, Sharifi H, Karamoozian A, Sharifi F, Khosravi A, Hassanzadeh S (2018) Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLoS ONE 13:e0192236","journal-title":"PLoS ONE"},{"key":"2113_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0020-7519(03)00126-7","volume":"33","author":"SI Belli","year":"2003","unstructured":"Belli SI, Monnerat S, Schaff C, Masina S, Noll T, Myler PJ, Stuart K, Fasel N (2003) Sense and antisense transcripts in the histone H1 (HIS-1) locus of Leishmania major. Int J Parasitol 33:965\u2013975","journal-title":"Int J Parasitol"},{"key":"2113_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","volume":"70","author":"CF Bennett","year":"2019","unstructured":"Bennett CF (2019) Therapeutic antisense oligonucleotides are coming of age. Annu Rev Med 70:307\u2013321","journal-title":"Annu Rev Med"},{"key":"2113_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00439-020-02130-w","volume":"139","author":"JM Blackwell","year":"2020","unstructured":"Blackwell JM, Fakiola M, Castellucci LC (2020) Human genetics of Leishmania infections. Hum Genet 139:813\u2013819","journal-title":"Hum Genet"},{"key":"2113_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ebiom.2018.09.029","volume":"36","author":"JB Carnielli","year":"2018","unstructured":"Carnielli JB, Crouch K, Forrester S, Silva VC, Carvalho SF, Damasceno JD, Brown E, Dickens NJ, Costa DL, Costa CH (2018) A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis. EBioMedicine 36:83\u201391","journal-title":"EBioMedicine"},{"key":"2113_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mimet.2014.11.014","volume":"108","author":"AK Crater","year":"2015","unstructured":"Crater AK, Manni E, Ananvoranich S (2015) Utilization of inherent miRNAs in functional analyses of Toxoplasma gondii genes. J Microbiol Methods 108:92\u2013102","journal-title":"J Microbiol Methods"},{"key":"2113_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1201\/9781003067474-19","volume-title":"Stress proteins in medicine","author":"PP de Andrade","year":"2020","unstructured":"de Andrade PP, de Andrade CR (2020) Heat shock proteins in visceral leishmaniasis. In: van Eden W, Young DB (eds) Stress proteins in medicine. Marcel Dekker, New York, pp 307\u2013325"},{"key":"2113_CR10","doi-asserted-by":"crossref","unstructured":"de Oliveira RM, de Ara\u00fajo Melo S, da Penha-Silva TA, Almeida-Souza F, Abreu-Silva AL (2018) Alternative treatment for leishmaniasis. In: Afrin F, Hemeg H (eds) Leishmaniases as re-emerging diseases, vol 145. IntechOpen, UK","DOI":"10.5772\/intechopen.75895"},{"key":"2113_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0972-9062.242557","volume":"55","author":"BR Esboei","year":"2018","unstructured":"Esboei BR, Mohebali M, Mousavi P, Fakhar M, Akhoundi B (2018) Potent antileishmanial activity of chitosan against Iranian strain of Leishmania major (MRHO\/IR\/75\/ER): in vitro and in vivo assay. J Vector Borne Dis 55:111","journal-title":"J Vector Borne Dis"},{"key":"2113_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009003","volume":"15","author":"MF Garc\u00eda-Bustos","year":"2021","unstructured":"Garc\u00eda-Bustos MF, Gonz\u00e1lez-Prieto G, Paniz-Mondolfi AE, Parodi C, Beckar J, Monroig S, Ramos F, Mora MC, Delgado-Noguera LA, Hashiguchi Y (2021) Risk factors for antimony treatment failure in American cutaneous leishmaniasis in Northwestern-Argentina. PLoS Negl Trop Dis 15:e0009003","journal-title":"PLoS Negl Trop Dis"},{"key":"2113_CR13","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1590\/s1678-9946201860008","volume":"60","author":"K Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez K, Diaz R, Ferreira AF, Garc\u00eda V, Paz H, Calzada JE, Ru\u00edz M, Laurenti M, Salda\u00f1a A (2018) Histopathological characteristics of cutaneous lesions caused by Leishmania viannia panamensis in Panama. Rev Inst Med Trop Sao Paulo 60:e8","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2113_CR14","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1038\/srep04231","volume":"4","author":"M Hashimoto","year":"2014","unstructured":"Hashimoto M, Nara T, Hirawake H, Morales J, Enomoto M, Mikoshiba K (2014) Antisense oligonucleotides targeting parasite inositol 1, 4, 5-trisphosphate receptor inhibits mammalian host cell invasion by Trypanosoma cruzi. Sci Rep 4:4231","journal-title":"Sci Rep"},{"key":"2113_CR15","first-page":"e2","volume":"48","author":"F Hentzschel","year":"2020","unstructured":"Hentzschel F, Mitesser V, Fraschka SA-K, Krzikalla D, Carrillo EH, Berkhout B, B\u00e1rtfai R, Mueller A-K, Grimm D (2020) Gene knockdown in malaria parasites via non-canonical RNAi. Nucleic Acids Res 48:e2\u2013e2","journal-title":"Nucleic Acids Res"},{"key":"2113_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217683","volume":"14","author":"NR Hussein","year":"2019","unstructured":"Hussein NR, Balatay AA, Saleem ZS, Hassan SM, Assafi MS, Sheikhan RS, Amedi FR, Hafzullah SS, Hafzullah MS, Xedr AM (2019) A clinical study of cutaneous leishmaniasis in a new focus in the Kurdistan region Iraq. PLoS ONE 14:e0217683","journal-title":"PLoS ONE"},{"key":"2113_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","volume":"17","author":"S Iborra","year":"2018","unstructured":"Iborra S, Solana JC, Requena JM, Soto M (2018) Vaccine candidates against Leishmania under current research. Expert Rev Vaccines 17:323\u2013334","journal-title":"Expert Rev Vaccines"},{"key":"2113_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.actatropica.2018.11.020","volume":"190","author":"M Karaku\u015f","year":"2019","unstructured":"Karaku\u015f M, Arserim SK, Kasap \u00d6E, Peka\u011f\u0131rba\u015f M, Ak\u00fcz\u00fcm D, Alten B, T\u00f6z S, \u00d6zbel Y (2019) Vector and reservoir surveillance study in a canine and human leishmaniasis endemic area in most western part of Turkey, Karaburun. Acta Trop 190:177\u2013182","journal-title":"Acta Trop"},{"key":"2113_CR19","first-page":"65","volume":"41","author":"F Kheirandish","year":"2012","unstructured":"Kheirandish F, Bandehpour M, Haghighi A, Mahboudi F, Mohebali M, Kazemi B (2012) Inhibition of Leishmania major PTR1 gene expression by antisense in Escherichia coli. Iran J Public Health 41:65","journal-title":"Iran J Public Health"},{"key":"2113_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11010-011-1007-y","volume":"359","author":"P Raina","year":"2012","unstructured":"Raina P, Kaur S (2012) Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani. Mol Cell Biochem 359:135\u2013149","journal-title":"Mol Cell Biochem"},{"key":"2113_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","volume":"14","author":"C Rinaldi","year":"2018","unstructured":"Rinaldi C, Wood MJ (2018) Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol 14:9\u201321","journal-title":"Nat Rev Neurol"},{"key":"2113_CR22","first-page":"jcs242776","volume":"134","author":"T Rosazza","year":"2021","unstructured":"Rosazza T, Lecoeur H, Blisnick T, Moya-Nilges M, Pescher P, Bastin P, Prina E, Sp\u00e4th GF (2021) Dynamic imaging reveals surface exposure of virulent Leishmania amastigotes during pyroptosis of infected macrophages. J Cell Sci 134:jcs242776","journal-title":"J Cell Sci"},{"key":"2113_CR23","doi-asserted-by":"publisher","first-page":"e23670","DOI":"10.1002\/jcla.23670","volume":"35","author":"M Sezavar","year":"2021","unstructured":"Sezavar M, Sharifi I, Ghasemi Nejad Almani P, Kazemi B, Davoudi N, Salari S, Salarkia E, Khosravi A, Bamorovat M (2021) The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica. J Clin Lab Anal 35:e23670","journal-title":"J Clin Lab Anal"},{"key":"2113_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/85671","volume":"19","author":"RP Stock","year":"2001","unstructured":"Stock RP, Olvera A, Sanchez R, Saralegui A, Scarfi S, Sanchez-Lopez R, Ramos MA, Boffa LC, Benatti U, Alagon A (2001) Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nat Biotechnol 19:231\u2013234","journal-title":"Nat Biotechnol"},{"key":"2113_CR25","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1002\/ange.202105942","volume":"133","author":"X Su","year":"2021","unstructured":"Su X, Ma W, Feng D, Cheng B, Wang Q, Guo Z, Zhou D, Tang X (2021) Efficient inhibition of SARS-CoV-2 using chimeric antisense oligonucleotides through Rnase L activation. Angew Chem 133:21830\u201321835","journal-title":"Angew Chem"},{"key":"2113_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molimm.2015.03.251","volume":"66","author":"S Teimourian","year":"2015","unstructured":"Teimourian S, Moghanloo E (2015) Role of PTEN in neutrophil extracellular trap formation. Mol Immunol 66:319\u2013324","journal-title":"Mol Immunol"},{"key":"2113_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/dna.2016.3317","volume":"35","author":"S Teimourian","year":"2016","unstructured":"Teimourian S, Moghanloo E (2016) Thwarting PTEN expression by siRNA augments HL-60 cell differentiation to neutrophil-like cells by DMSO and ATRA. DNA Cell Biol 35:591\u2013598","journal-title":"DNA Cell Biol"},{"key":"2113_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0972-9062.263718","volume":"56","author":"F Tohidi","year":"2019","unstructured":"Tohidi F, Babaei Z, Kazemi B, Bandehpour M, Sharifi I, Rabiei MR, Saedi Dezaki E (2019) Transient knockdown of nucleoside transporter 4 gene expression as a therapeutic target in Leishmania major by antisense RNA: In vitro and in vivo studies. J Vector Borne Dis 56:98\u2013104","journal-title":"J Vector Borne Dis"},{"key":"2113_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.nano.2017.12.026","volume":"14","author":"X-Y Xue","year":"2018","unstructured":"Xue X-Y, Mao X-G, Zhou Y, Chen Z, Hu Y, Hou Z, Li M-K, Meng J-R, Luo X-X (2018) Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases. Nanomed Nanotechnol Biol Med 14:745\u2013758","journal-title":"Nanomed Nanotechnol Biol Med"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-025-02113-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:41:44Z","timestamp":1757209304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-025-02113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1007\/s10482-025-02113-9","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"type":"print","value":"0003-6072"},{"type":"electronic","value":"1572-9699"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"108"}}